ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
NervGen Pharma Corp.
2.06
-0.0800
-3.74%
盤後:
2.05
-0.0092
-0.45%
18:44 EDT
成交量:
80.74萬
成交額:
170.05萬
市值:
2.18億
市盈率:
-4.54
高:
2.20
開:
2.10
低:
2.05
收:
2.14
52周最高:
6.30
52周最低:
1.70
股本:
1.06億
流通股本:
9,418.02萬
量比:
0.81
換手率:
0.86%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.4537
每股收益(LYR):
-0.4448
淨資產收益率:
-1207.46%
總資產收益率:
-90.75%
市淨率:
56.02
市盈率(LYR):
-4.63
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善
美股速递
·
05/26
熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌
路透中文
·
05/22
NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行
美股速递
·
05/22
NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途
美股速递
·
05/22
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NGEN"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","market":"US","secType":"STK","nameCN":"NervGen Pharma Corp.","latestPrice":2.06,"timestamp":1782244800000,"preClose":2.14,"halted":0,"volume":807365,"hourTrading":{"tag":"盘后","latestPrice":2.0508,"preClose":2.06,"latestTime":"18:44 EDT","volume":2209,"amount":4539.977,"timestamp":1782254640017,"change":-0.0092,"changeRate":-0.004466,"amplitude":0.016505},"delay":0,"changeRate":-0.03738317757009349,"floatShares":94180200,"shares":106000000,"eps":-0.45375,"marketStatus":"未開盤","change":-0.08,"latestTime":"06-23 16:00:00 EDT","open":2.1,"high":2.2,"low":2.05,"amount":1700507.5255870002,"amplitude":0.070093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.45375,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1782288000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.14,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.14,"latestTime":"09:19 EDT","volume":205,"amount":450.87972649999995,"timestamp":1782220783417,"change":0.02,"changeRate":0.009346,"amplitude":0.023224},"postHourTrading":{"tag":"盘后","latestPrice":2.0508,"preClose":2.06,"latestTime":"18:44 EDT","volume":2209,"amount":4539.977,"timestamp":1782254640017,"change":-0.0092,"changeRate":-0.004466,"amplitude":0.016505},"volumeRatio":0.807312,"impliedVol":0.2913,"impliedVolPercentile":0.1143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGEN\",,,,,undefined,":{"symbol":"NGEN","floatShares":94180200,"roa":"-90.75%","roe":"-1207.46%","lyrEps":-0.444846,"volumeRatio":0.807312,"shares":106000000,"dividePrice":0,"high":2.2,"amplitude":0.070093,"preClose":2.14,"low":2.05,"week52Low":1.7,"pbRate":"56.02","week52High":6.3,"institutionHeld":0,"latestPrice":2.06,"eps":-0.45375,"divideRate":0,"volume":807365,"delay":0,"ttmEps":-0.45375,"open":2.1,"prevYearClose":5.6,"prevWeekClose":2.2,"prevMonthClose":2.07,"prevQuarterClose":3.77,"fiveDayClose":1.86,"twentyDayClose":2.08,"sixtyDayClose":3.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"NGEN","fiscalQuarterEnding":"2026/03","expectedEps":-0.07,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.09},{"date":"2026-03-31","symbol":"NGEN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"盤前","dateTimestamp":1774929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":8,"updateTime":1781236800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGEN","date":"2026-06-22","current":-4.539945,"percent":0.837838,"low":-25.148356,"twenty":-17.852833,"median":-15.828582,"eighty":-9.350047,"high":-6.149004,"avg":-13.879145,"sd":5.297229,"marketCap":233646899},"quantilePoints":[{"date":"2026-01-09","current":-25.148356,"twenty":-24.98651,"median":-24.743741,"eighty":-24.500973,"marketCap":463798962.95},{"date":"2026-01-16","current":-23.484013,"twenty":-24.651705,"median":-24.262661,"eighty":-23.546305,"marketCap":432253265.53},{"date":"2026-01-23","current":-22.238177,"twenty":-24.339127,"median":-23.484013,"eighty":-22.456198,"marketCap":412101315.23},{"date":"2026-01-30","current":-17.441707,"twenty":-24.262661,"median":-22.611928,"eighty":-20.307131,"marketCap":329508465.32},{"date":"2026-02-06","current":-16.382746,"twenty":-23.795472,"median":-22.238177,"eighty":-17.908896,"marketCap":306238051.42},{"date":"2026-02-13","current":-17.441707,"twenty":-23.484013,"median":-19.886661,"eighty":-17.285978,"marketCap":327197651.85},{"date":"2026-02-20","current":-18.220355,"twenty":-23.359429,"median":-18.282647,"eighty":-17.285978,"marketCap":340388899.6},{"date":"2026-02-27","current":-17.753166,"twenty":-22.879782,"median":-18.03348,"eighty":-17.410561,"marketCap":331850071.27},{"date":"2026-03-06","current":-17.223686,"twenty":-22.51849,"median":-17.893323,"eighty":-17.27352,"marketCap":321208516.98},{"date":"2026-03-13","current":-16.382746,"twenty":-22.306698,"median":-17.753166,"eighty":-16.993207,"marketCap":307553178.63},{"date":"2026-03-20","current":-16.957011,"twenty":-22.250635,"median":-17.753166,"eighty":-16.888553,"marketCap":316207550},{"date":"2026-03-27","current":-15.785094,"twenty":-21.714925,"median":-17.597437,"eighty":-16.837477,"marketCap":291516280},{"date":"2026-04-02","current":-18.89617,"twenty":-20.942507,"median":-17.535145,"eighty":-16.702393,"marketCap":347270760},{"date":"2026-04-10","current":-10.676925,"twenty":-19.970755,"median":-17.441707,"eighty":-16.494872,"marketCap":340718966},{"date":"2026-04-17","current":-10.464421,"twenty":-19.238183,"median":-17.254832,"eighty":-16.110604,"marketCap":336672423},{"date":"2026-04-24","current":-9.863583,"twenty":-18.837636,"median":-17.005665,"eighty":-12.953446,"marketCap":318058323},{"date":"2026-05-01","current":-9.064424,"twenty":-18.587877,"median":-16.950192,"eighty":-10.62677,"marketCap":293779061},{"date":"2026-05-08","current":-9.632569,"twenty":-18.344939,"median":-16.86331,"eighty":-10.287304,"marketCap":311583853},{"date":"2026-05-15","current":-9.34654,"twenty":-18.295105,"median":-16.834362,"eighty":-10.043494,"marketCap":300253531},{"date":"2026-05-22","current":-9.812417,"twenty":-18.145605,"median":-16.66306,"eighty":-9.800918,"marketCap":297825605},{"date":"2026-05-29","current":-7.287863,"twenty":-18.008563,"median":-16.66306,"eighty":-9.72533,"marketCap":220902522},{"date":"2026-06-05","current":-7.091826,"twenty":-17.902667,"median":-16.382746,"eighty":-9.634252,"marketCap":213468303},{"date":"2026-06-12","current":-6.717699,"twenty":-17.87775,"median":-16.216296,"eighty":-9.423447,"marketCap":200723927},{"date":"2026-06-18","current":-7.855923,"twenty":-17.87775,"median":-15.872071,"eighty":-9.364073,"marketCap":232584867},{"date":"2026-06-22","current":-7.907765,"twenty":-17.852833,"median":-15.828582,"eighty":-9.350047,"marketCap":233646899}],"updateTime":1782267445952},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGEN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133039688","title":"NervGen Pharma Corp - Nvg-291在1B/2a期Connect Sci研究中顯示出統計學顯著的步態質量改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1133039688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133039688?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 19:16","pubTimestamp":1779794209,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp. 宣布,其研究性药物Nvg-291在针对多发性硬化症患者的1B/2a期Connect Sci临床研究中,取得了具有统计学显著意义的步态质量改善。研究数据显示,与安慰剂组相比,接受Nvg-291治疗的患者在步态分析的关键指标上表现出显著提升。Nvg-291是一种旨在促进神经修复和功能恢复的新型疗法。公司表示,将继续推进相关临床开发计划,以进一步评估Nvg-291在更广泛神经系统适应症中的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637237354","title":"熱門話題-NervGen Pharma因發行股票及認股權證而股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2637237354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637237354?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:29","pubTimestamp":1779395349,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nL4T41Y24J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174712044","title":"NervGen Pharma Corp啓動普通股、認股權證及預融資認股權證承銷公開發行","url":"https://stock-news.laohu8.com/highlight/detail?id=1174712044","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174712044?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393853,"startTime":"0","endTime":"0","summary":"NervGen Pharma Corp.宣布,公司已启动一项承销公开发行,将发行普通股、认股权证及预融资认股权证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102911496","title":"NervGen Pharma 公司——淨收益將用於推進Nvg-291臨床研究及一般公司用途","url":"https://stock-news.laohu8.com/highlight/detail?id=1102911496","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102911496?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393852,"startTime":"0","endTime":"0","summary":"NervGen Pharma 公司宣布,此次融资所得净收益将主要用于推进其核心候选药物Nvg-291的临床研究,并支持公司的一般运营与战略发展。此举旨在加速该疗法的开发进程,为未来的商业化奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NGEN\",params:#limit:6,delay:false,,,undefined,":[]}}